Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Endocrine ; 43(1): 191-9, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22851332

RESUMEN

Sex hormone receptors, androgen receptor (AR) and estrogen receptors (ERs) including both ERα and ERß, mediate the actions of sex hormones. In this study, we aimed to evaluate sex hormone receptors expression in upper urinary tract urothelial carcinomas (UUTUCs) of ureter and renal pelvis with different tumor stages and grades as well as their possible roles in tumor progression. Immunohistochemistry was used to assay the expression of AR and ERs in the primary UUTUCs. XTT viability test was applied to evaluate cell responses for anticancer drug treatment. Wound healing assay was performed to determine cell migration abilities. AR and ERß immunoreactivities were observed in both UUTUCs, but ERα was not detected in either UUTUCs. In UUTUC of ureter specimens, higher AR expression was found in superficial or lower grade tumors. In contrast, little difference of ERß expression was found in superficial versus muscle-invasive tumor stages or low grades versus high grades in UUTUCs of ureter specimens. Furthermore in the primary cultured cells from UUTUC specimens, the addition of functional AR reduced cell chemosensitivity, but increased cell migration. These results provide the first data showing the expression patterns of sex hormone receptors in both renal pelvis and ureter UUTUCs. From results, we concluded that there is a positive correlation for higher AR expression found in superficial or low-grade UUTUCs of ureter and identified the functional roles of AR in UUTUC progression.


Asunto(s)
Carcinoma/metabolismo , Regulación Neoplásica de la Expresión Génica , Pelvis Renal/metabolismo , Proteínas de Neoplasias/metabolismo , Receptores Androgénicos/metabolismo , Uréter/metabolismo , Neoplasias Urológicas/metabolismo , Anciano , Anciano de 80 o más Años , Antineoplásicos/farmacología , Carcinoma/tratamiento farmacológico , Carcinoma/patología , Línea Celular Tumoral , Movimiento Celular , Resistencia a Antineoplásicos , Femenino , Humanos , Neoplasias Renales/tratamiento farmacológico , Neoplasias Renales/metabolismo , Neoplasias Renales/patología , Pelvis Renal/efectos de los fármacos , Pelvis Renal/patología , Masculino , Persona de Mediana Edad , Clasificación del Tumor , Proteínas de Neoplasias/biosíntesis , Proteínas de Neoplasias/genética , Estadificación de Neoplasias , ARN Mensajero/metabolismo , Receptores Androgénicos/biosíntesis , Receptores Androgénicos/genética , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/metabolismo , Células Tumorales Cultivadas , Uréter/efectos de los fármacos , Uréter/patología , Neoplasias Ureterales/tratamiento farmacológico , Neoplasias Ureterales/metabolismo , Neoplasias Ureterales/patología , Neoplasias Urológicas/tratamiento farmacológico , Neoplasias Urológicas/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA